Navigation Links
PET imaging significantly enhances standard imaging in lung cancer staging
Date:11/27/2007

November 27, 2007, 4:00 p.m. E.S.T. - Positron emission tomography (PET) is a useful diagnostic tool that supports the need for more accurate staging of lung cancer and improved treatment for patients, concludes an extensive systematic review published online today in Journal of National Cancer Institute.

The review conducted by the Lung Cancer Disease Site Group of Cancer Care Ontarios Program in Evidence-Based Care led by a Sunnybrook researcher, Dr. Yee Ung, evaluates the accuracy and utility of 18-fluorodeoxyglucose PET (18FDG-PET) in the diagnosis and staging of lung cancer.

Lung cancer remains the leading cause of cancer-related death and early diagnosis provides the best chance for long term survival, says Dr. Ung, chair, Lung Cancer Site Group, Odette Cancer Centre, Sunnybrook. It is our hope this systematic review contributes to clinical guideline discussions exploring the potential of PET as part of standard preoperative work-up - along with computed tomography (CT) - to further enhance assessment of early-stage lung cancer.

While the standard imaging technologies CT provide structural information and defines disease states based on anatomical changes, PET provides complementary information on biochemical processes that may precede gross anatomical changes.

Key findings drawn from the literature review include PET imaging is accurate in differentiating between benign and malignant lung tumours as small as 1 centimetre. PET was also shown to be more effective for mediastinal (lymph nodes in the centre of the chest) staging in non-small cell lung cancer. Nonetheless, confirmation of PET findings by surgical biopsy remains important. With best available data, the researchers also identified good accuracy in staging extensive versus limited stage small cell lung cancer.

The Lung Cancer Disease Site Group of Cancer Care Ontarios Program in Evidence-Based Care reviewed recent relevant health technology assessments, randomized trials and meta-analyses and also took into consideration studies evaluating the utility of PET.

Future research is needed to determine not only if PET should be integrated into the standard staging and diagnostic processes of lung cancer but also how PET would be incorporated into the staging algorithm, says Ung.

In 2007, an estimated 23,300 Canadians will be diagnosed with lung cancer and 19,900 will die of it. The total number of lung cancer deaths (men and women combined) is greater than the number of either prostate or breast cancer related deaths combined. According to Lung Cancer Canada, in 2006, almost 23,000 Canadians were diagnosed with the disease and another 27,000 cases are expected to be diagnosed this year.


'/>"/>

Contact: Natalie Chung-Sayers
416-480-4040
Sunnybrook Health Sciences Centre
Source:Eurekalert

Related medicine news :

1. Brain imaging reveals breakdown of normal emotional processing
2. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
3. Fry Construction Selected for High-Profile Medical Imaging Project
4. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
5. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
6. Imaging Software Helps Track, Treat Injured Brains
7. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS)
10. Brain Imaging Expert Recruited to Study Autism at The Childrens Hospital of Philadelphia
11. Medical Imaging Revolutionizes Modern Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... DC (PRWEB) , ... February 11, 2016 , ... ... an upcoming Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for ... not-for-profit Catholic health care system that’s partnering with Intel on value-based health benefits ...
(Date:2/11/2016)... ... February 11, 2016 , ... PharmMD CEO ... Garrett will focus on contract negotiations, corporate strategy and healthcare data law. Additional ... best practices in data breaches for the Part D Star Rating improvement and ...
(Date:2/11/2016)... ... 11, 2016 , ... AccuVein Inc. announces the Infusion Nurses ... Practice, to include vascular visualization as a standard practice. AccuVein ( http://www.accuvein.com ), ... market, facilitates adherence to this standard with its easy to use, widely deployed ...
(Date:2/11/2016)... ... February 11, 2016 , ... The annual list showcases the 20 Most ... DataPoint’s team dedication and commitment to the SharePoint ecosystem. A panel of experts ... panel’s goal is to recognize and promote technology entrepreneurship. , The survey was ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hoggan Scientific, ... gauges used in physical therapy, occupational therapy and sports medicine clinics, hospitals, universities ... exercise and therapy, introduces its new microFET Digital Pinch Gauge. , Hoggan ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for ... Company also filed its Quarterly Report on Form 10-Q for ... and Exchange Commission today. --> ... --> --> Net sales for the three ... to $5.4 million from $2.8 million for the three months ...
(Date:2/11/2016)... 11, 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ... the lives of pets, today announced the submission to ... Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  ... of Zimeta for the control of pyrexia (fever) in ... --> --> The Chemistry, Manufacturing, ...
(Date:2/11/2016)... , Feb. 11, 2016  Governor Andrew M. ... will create 1,400 jobs throughout Western New ... partnership with the SUNY Polytechnic Institute, includes a major ... Building in Buffalo , as well ... manufacturing facility in Dunkirk . The ...
Breaking Medicine Technology: